SUN — Surgical Innovations Cashflow Statement
0.000.00%
Last trade - 00:00- £4.66m
- £5.11m
- £12.01m
- 21
- 75
- 17
- 28
Annual cashflow statement for Surgical Innovations, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.62 | -3.28 | -0.456 | 0.264 | -0.509 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2.57 | 1.55 | 0.02 | -0.27 | -0.031 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.613 | 1.8 | -0.844 | -0.095 | 0.183 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.594 | 1.04 | -0.433 | 0.486 | 0.4 |
| Capital Expenditures | -0.516 | -0.155 | -0.657 | -1.08 | -0.688 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.516 | -0.155 | -0.657 | -1.08 | -0.688 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.34 | 3.15 | -0.532 | -0.935 | -0.672 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.21 | 4 | -1.63 | -1.45 | -0.987 |